Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy is a genetically determined myocardial disease with a diverse natural history. 1 – 7 Since a subgroup of patients with hypertrophic cardiomyopathy are at high risk for sudden death, there has been considerable interest in risk stratification 1 , 3 , 8 – 11 and appropriate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2000-02, Vol.342 (6), p.365-373
Hauptverfasser:	Maron, Barry J, Shen, Win-Kuang, Link, Mark S, Epstein, Andrew E, Almquist, Adrian K, Daubert, James P, Bardy, Gust H, Favale, Stefano, Rea, Robert F, Boriani, Giuseppe, Estes, N.A. Mark, Spirito, Paolo, Casey, Susan A, Stanton, Marshall S, Betocchi, Sandro
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Biological and medical sciences Cardiomyopathy, Hypertrophic - complications Cardiomyopathy, Hypertrophic - therapy Cardiovascular disease Child Death, Sudden, Cardiac - etiology Death, Sudden, Cardiac - prevention & control Defibrillators, Implantable - adverse effects Diseases of the cardiovascular system Equipment Failure Female Health risk assessment Humans Male Medical equipment Medical sciences Middle Aged Mortality Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Retrospective Studies Risk Factors Tachycardia, Ventricular - etiology Tachycardia, Ventricular - prevention & control Transplants & implants Ventricular Fibrillation - etiology Ventricular Fibrillation - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!